Consolidated Communications to Release Fourth-Quarter 2017 Earnings on March 1
Feb 08, 2018 21:41 pm UTC| Business
MATTOON, Ill., Feb. 08, 2018 -- Consolidated Communications Holdings, Inc. (Nasdaq:CNSL) will release its fourth quarter 2017 financial results on Mar 1, 2018 before the market opens. The Company will host a conference...
Artisan Partners Asset Management Inc. Reports January 2018 Assets Under Management
Feb 08, 2018 21:40 pm UTC| Business
MILWAUKEE, Feb. 08, 2018 -- Artisan Partners Asset Management Inc. (NYSE:APAM) today reported that its assets under management (AUM) as of January 31, 2018 totaled $122.3 billion. Separate accounts accounted for $61.5...
Feb 08, 2018 21:36 pm UTC| Business
NEW YORK, Feb. 08, 2018 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of TESARO, Inc. (NASDAQ:TSRO) from March 14, 2016...
Aduro Biotech to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Feb 08, 2018 21:31 pm UTC| Business
BERKELEY, Calif., Feb. 08, 2018 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the Leerink Partners 7th Annual...
Mackinac Financial Corporation Reports 2017 Fourth Quarter and Annual Results
Feb 08, 2018 21:30 pm UTC| Business
MANISTIQUE, Mich., Feb. 08, 2018 -- Mackinac Financial Corporation (Nasdaq:MFNC) (the “Corporation”), the bank holding company for mBank, today announced 2017 net income of $5.48 million, or $.87 per share, compared to...
Franklin Resources, Inc. Announces Month-End Assets Under Management
Feb 08, 2018 21:30 pm UTC| Business
SAN MATEO, Calif., Feb. 08, 2018 -- Franklin Resources, Inc. (Franklin Templeton Investments) (NYSE:BEN) today reported preliminary month-end assets under management of $770.8 billion at January 31, 2018, compared to...
CRISPR Therapeutics Announces Transition of Bill Lundberg, MD
Feb 08, 2018 21:30 pm UTC| Business
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 08, 2018 -- CRISPR Therapeutics (Nasdaq:CRSP), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, today announced that...